Makes plasma collection devices for pharmaceutical manufacturers.
Jun 2026Revenue $1.35B/yrExpenses $1.19B/yr
Reached break-even Jul 2017
Figures by year
When did Haemonetics become profitable?
Its revenue passed its expenses in Jul 2017. In the 12 months to Jun 2026, revenue was $1.35B and expenses $1.19B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $1.33B | $1.18B | $157M |
| Mar 2025 | $1.36B | $1.14B | $222M |
| Mar 2024 | $1.31B | $1.14B | $165M |
| Apr 2023 | $1.17B | $1.01B | $156M |
| Apr 2022 | $993M | $912M | $80.8M |
| Apr 2021 | $870M | $781M | $89.7M |
| Mar 2020 | $988M | $885M | $103M |
| Mar 2019 | $968M | $884M | $83.5M |
| Mar 2018 | $904M | $848M | $56.2M |
| Apr 2017 | $886M | $905M | −$19.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.